Senior insider sale
President and CEO at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$6.35M
14.89K shares
What this filing means
SIBOLD WILLIAM JOHN plans to sell 14.89K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $6.35M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/9/2025ACC: 0001104659-25-088744
DirectorOfficer· President and CEO
Since Mar 2026
14.89K
Shares to sell
$6.35M
Approx. market value
7.28K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
9/8/2025
7.28KTotal acquired7.28K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/8/2025 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 7.28K | — |
| Total | 7.28K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.62K
Market value
$3.05M
8/21/2025
Planned — Approximate Date
Nasdaq Stock MarketPlanned
Units to sell
7.28K
Market value
$3.30M
9/9/2025
Total
Units
14.89K
Value
$6.35M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/21/2025 | 7.62K | $3.05M | — | Completed |
| Planned — Approximate Date | ||||
9/9/2025 | 7.28K | $3.30M | Nasdaq Stock Market | Planned |
| Total | 14.89K | $6.35M | ||